Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Ocean (042660) Amends FCS Contract with Oceania Shipowner to Increase Value to KRW 902.8B

Posted on April 24, 2026July 17, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Ocean (042660) Amends FCS Contract with Oceania Shipowner to Increase Value to KRW 902.8B

Source of Facts: Financial Supervisory Service DART / 2026-04-24

Disclosure Type: Execution of Single Sales/Provider Contract (Amendment)

💡 3-Second Summary

Hanwha Ocean has amended its FCS construction contract with an Oceanian shipowner, adjusting the contract value from KRW 899.4 billion to KRW 902.8 billion and removing prior text regarding storage fee settlements, provided that all contents are subject to change during the project execution process.

📊 1. [Key Disclosure Content & Major Figures Summary]

  • Reason for Amendment: Changes in contract value and deletion of specific text under other investment considerations.
  • Amended Items:
    • Contract Value: (Before) KRW 899,400,000,000 ➡️ (After) KRW 902,800,000,000
    • Proportion of Annual Sales: (Before) 4.0% ➡️ (After) 12.8% (Calculated based on the company’s annual sales of KRW 7,030,200,000,000 from the 2020 consolidated financial statements)
    • Other Investment Considerations: (Before) “4. The contract amount has been reduced as the temporary storage fees previously included in the contract amount were converted into the actual settled amount during this agreement process as the storage period was confirmed.” ➡️ (After) Text deleted.
  • Contract Name & Quantity: Construction of 1 Field Control Station (FCS) Unit
  • Contract Counterparty: Shipowner based in the Oceanian region
  • Sales & Distribution Region: Oceania
  • Contract Period: February 1, 2022 ~ April 3, 2027
  • Initial Contract Execution Date: January 10, 2022
  • Key Contract Terms:
    • Down payment/prepayment not included (No payment upon signing).
    • Payment terms: Structured progressively based on construction milestones.
  • Currency Calculations: This is a multi-currency contract, calculated by applying the trading standard exchange rates as of January 10, 2022 (1 USD = 1,202.40 KRW, 1 GBP = 1,633.94 KRW, 1 EUR = 1,365.69 KRW, 1 AUD = 863.02 KRW, 1 NOK = 136.11 KRW, 1 MYR = 285.67 KRW).
  • Project Scope: Consists of two phases: Phase 1 design verification and construction preparation, followed by Phase 2 construction execution.
  • Project Variability Clause: The contract period and final settlement amount are subject to change during the course of the project execution process.

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Official Amendment of Financial Terms: This disclosure formally reports the adjustment of quantitative parameters for the offshore facility construction contract originally signed on January 10, 2022. The contract value has been changed to KRW 902.8 billion, representing 12.8% of the company’s 2020 consolidated annual sales.
  • Administrative Correction of Payout Clause: The explanatory text regarding temporary storage fee settlements that was registered in the previous amendment has been officially deleted through this filing, indicating an administrative cleanup of the disclosure wording.
  • Long-Term Timelines and Inherent Flexibility: The contract period remains scheduled from February 1, 2022, to April 3, 2027. This multi-currency transaction utilizes progress-based payment schedules. As explicitly stated in the source text, both the contract period and final settlement amounts remain subject to subsequent modifications depending on actual project developments.

📝 Editor’s Comment (by K-STOCK Editor)

Hanwha Ocean’s amended filing regarding its single sales and supply contract officially reports the adjustments in the specific value and historical text parameters of its offshore FCS project with an Oceanian shipowner. According to the document, the total contract value has been adjusted to KRW 902.8 billion, and the previous wording regarding storage fee settlements has been deleted.

The critical variable and primary checkpoints for investors to watch moving forward are the ‘inherent variability of multi-currency calculations’ and the explicit condition that ‘the parameters remain subject to change during project execution.’ Because this project is structured around progressive milestone payments and was calculated based on historical exchange rates from January 2022 across multiple foreign currencies, the final settlement parameters are subject to future adjustments.

Consequently, investors should avoid drawing definitive conclusions regarding fixed financial performance based on the mere amendment of historical contract parameters. It remains essential to monitor the project’s progress through its scheduled completion on April 3, 2027, under the explicit conditions stated in the filing, which indicate that both the final settlement values and timelines remain subject to future adjustments as the construction proceeds.

📢 Disclaimer & Source Information

Source: This content was newly structured and written based on the official data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Advisory: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Shipbuilding

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) Negotiating Specific Contract Terms Following Binding MOU for K9 Production in Spain (Unconfirmed Re-disclosure)
Next Post: [Disclosure] Celltrion (068270) Obtains MFDS Approval for Phase 3 Clinical Trial Protocol Amendment of Keytruda Biosimilar ‘CT-P51’ in South Korea

Related Posts

[Disclosure] Celltrion (068270) Secures US FDA Approval for Phase 3 Clinical Trial Plan (IND) of ‘Darzalex Biosimilar (CT-P44)’ Disclosures
[Disclosure] Daeduck Electronics (353200) Slates AGM for Mar 27; Proposes KRW 400 Dividend & Re-election of 30-Year Veteran CFO Semiconductors
Alteogen(196170) to Host Large-Scale Overseas IR in Hong Kong and Singapore, Unveiling R&D Pipelines to Global Institutional Investors Disclosures
[Disclosure] SK hynix (000660) Declares Q1 Quarterly Cash Dividend of KRW 300/Share, Payout Totaling ~KRW 206.5B Semiconductors
[Disclosure] PSK Holdings (031980) Designated as Investment Warning Stock After 200% Surge in 1 Year Semiconductors
[Disclosure] Celltrion Reports Q3 2024 Preliminary Separate Revenue of KRW 1.04T and Operating Profit of KRW 461.7B (068270) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme